The joint venture company, which recently commissioned its Rs 75-crore poultry vaccine manufacturing unit in Medak district, has applied for eight fresh licences for vaccine production.

“We are at present producing six poultry vaccines and have applied for eight more, which we expect to receive in the next six to nine months,” according to Dr D.K. Dey, CEO of Globion.

The Hindu Business Line reports that the company will be producing about 25 per cent of the plant capacity of 5,000 doses annually in this fiscal.

“We will be scaling up the production to full capacity in the next three to four years, by which time we expect to breakeven,” he told press persons.

Globion, in which Suguna has 74 per cent stake, is producing the vaccines using technology from Lohmann, a global player in the animal vaccines market. It is competing in the domestic market with MNC players such as Intervet, Merial and Abic, apart from local players such as Venky's Vaccines, Inbovac and Hester.

The total domestic animal vaccine market size is estimated at Rs 2,000 crore, with the poultry segment accounting for Rs 150 crore.

“Among the eight new licences we have applied for is one vaccine that we are developing with technology from Tamil Nadu Veterinary University – this product can be stored in room temperature and hence does not require special infrastructure,” Dr Dey said.